Francesco Bracotti

Experience

• 

  Pharmacies (various)

  Jan 2013 - Jan 2017

  Pharmacy Manager (Transitional Leadership Role) & Trainee Pharmacist

  Following the passing of my father, I took over the management of our family pharmacy in Italy for two transitional years, overseeing daily operations, defining sales targets, and leading a team of 11 people through a period of strategic realignment. During this time, I also conducted due diligence and successfully negotiated an M&A agreement. Earlier, as a trainee pharmacist in Spain, I developed lab workflow procedures and managed relationships with key accounts, gaining hands-on experience in both technical and customer-facing aspects of the role. Show less

• 

  NanoMug

  Jan 2018 - now

  Inventor

  I am the inventor of a globally multi-patented pharmaceutical platform, supported by scientific evidence published in a Q1 top-3 journal and recognized among Wiley’s top 10% most downloaded articles. I developed the business model to secure funding, and led benchmarking activities to define key differentiators - earning top project recognition from a world top-5 university incubator in 2021. I have driven business development and partnerships, while leveraging global academic networks to advance preclinical development and prepare for regulatory and commercial milestones. Show less

• 

  Sanofi

  Jan 2019 - Jan 2019

  Market Access & HEOR Associate, Specialty Care

  As part of the Market Access & HEOR team in Specialty Care, I contributed to shaping the pricing and reimbursement strategy for Dupixent®, with a strong focus on its dermatology indication in atopic dermatitis. I developed the budget impact model, cost-effectiveness analysis, and contracting tools that supported both national and regional negotiations, helping to demonstrate the clinical and economic value of the treatment in dermatology. In parallel, I contributed to the preparation of P&R dossiers, ensuring alignment with market expectations and payer needs. Show less

• 

  GSK

  Jan 2019 - now

  I led two sales teams (14 FTEs), cultivating a high-performing, people-first culture that elevated One80 feedback from 3.4/5 to 4.9/5 - well above industry average - and drove Ellipta’s performance. I focused on building trust, driving executional excellence, and aligning the team around a shared sense of purpose, while managing effectively across all levels and engaging key external stakeholders. Alongside this, I led a regional omnichannel project for the Hematology Launch Team in Northwestern Europe, partnering with INSEAD and coordinating 4 MBA teams to support the launch of Blenrep® and improve the RRMM patient journey across the region.Recognized as a top performer and awarded GSK’s Global Gold Award for reshaping business thinking across Northwestern Europe, alongside global recognitions for “Accountable for Impact” and “Ambitious for Patients” as Sales Leader. Show less Appointed Global President of the INSEAD Healthcare Club, where I led a team of 14 and created value for the global INSEAD healthcare community through strategic initiatives, industry engagement, and cross-campus collaboration. During this time, I also led a global roadshow with the GSK Board of Directors, sharing insights and inspiring over 500 graduates worldwide. This experience strengthened my ability to influence across diverse audiences and connect strategic thinking with purpose-driven leadership. GSK’s global “Do the Right Thing” award in recognition of the impact and integrity demonstrated throughout these initiatives. Show less I led the end-to-end go-to-market strategy and local emergency use launch of Xevudy® for COVID-19, coordinating regulatory submission, access strategy, supply chain, forecasting, and launch readiness. I managed the cross-functional business plan and set strategic priorities across medical, access, and commercial to optimize the COVID care pathway. I also drove pre-launch assessments for pipeline assets, applying financial modeling, forecasting, competitive intelligence, and market insights. Through close collaboration with key external stakeholders and global teams, I identified and executed innovative partnerships and ensured alignment across regions. I defined demand plans, led the omnichannel communication strategy, and ensured strong internal engagement around launch plans and product evolution. GSK’s global recognitions for “Patient-focus” and “Development”; appointed Global Learning Ambassador for the Commercial Future Leaders Program. Show less I managed the transformation of a multi-therapy portfolio (Dermatology, Anti-Infectives, CNS, Respiratory, Urology) during COVID, driving a shift toward digital engagement and optimized budget allocation to improve profitability, expand reach, and strengthen Share of Voice. Prior to that, I restructured the field force to better align with brand maturity, implementing a leaner structure and introducing a remote engagement model. In parallel, I redesigned commercial incentives and channel strategies to accelerate sell-out in pharmacies and wholesale, led the rollout of an omnichannel approach with tailored HCP journeys, and drove targeted initiatives to compete effectively against generics - sustaining brand value and differentiation in highly competitive segments.GSK’s global "Teamwork" award; appointed Global Lead for the development of the Future Leaders program, fostering cross-market collaboration and talent growth. Show less

  • Sales Leader

    Jan 2023 - now

  • INSEAD MBA Leave of Absence

    Jan 2022 - Jan 2023

  • Sales Account Manager, Oncology

    Jan 2021 - Jan 2022

  • Senior Brand Manager & Acting Commercial Lead, COVID & Specialty Pipeline - Italy

    Jan 2020 - Jan 2021

  • Brand Manager, General Medicines

    Jan 2019 - Jan 2020